Description
AGENDA
Cambridge Biosafety Committee
Thursday, April 16, 2015, 3:00 pm
119 Windsor Street, Cambridge
Link to Agenda (pdf)
Presentations
- Glaxo Smith Klein (TBD) will present a request for a new BSL-1/BSL-2/BSL-3 permit at an existing location (45 Sidney Street), which has been permitted under Novartis Vaccines and Diagnostics until this year
- Abccam (Josh Withlow) will present a request for a new BSL-2 permit at One Kendall Square, Bldg 200, Suite B2304
- Semma Therapeutics (Robert Millman) will present a request for a new BSL-1/BSL-2 permit at 790 Memorial Drive (Science Hotel).
- Agios Pharaceuticals (Sarah Augood) will present a request for an amendment to their current BSL-1/BSL-2 permit to reflect relocation to 88 Sidney Street.
Old Business/Site visits
- 3/20 – Enumeral Biomedical (200 CambridgePark Drive) inspected for amendment to current BSL-1/BSL-2 permit to reflect a relocation.
- 3/23 – Navitor (1030 Mass. Ave.) inspected for new BSL-1/BSL-2 permit
- 3/23 – Addgene (75 Sidney St.) inspected for amendment to current BSL-1 permit at new location.
- 4/7 – Genocea (100 Acorn Park) inspected for amendment to current BSL-1/BSL2 permit
- 4/7 – Amgen (200 CambridgePark Drive) inspected for amendment to current BSL-1/BSL-2 permit at new location.
- 4/7 – Rubius (620 Memorial Drive) inspected for new BSL-1/BSL-2 permit
New Business
Adjourn